Tuesday, 12 February 2008

2007_07_01_archive



Autism and the gut

Ben Goldacre's dissection of the woeful Observer autism article

(defended by the Observer's readers' editor, and oh so unconnected

with the same journalist's interview with Wakefield before his GMC

hearing) has finally been published in the Guardian and the BMJ.

I don't need to bang on any more on that topic, but something that has

baffled me is the continuing support for Wakefield from so many

parents. What is it that the MMR 'link' with autism does for them? I

suppose it gives them someone to blame (or sue), and perhaps lets them

off the hook if they have the misguided worry that it is somehow their

fault (say from upbringing or genetics), although I'm not too sure how

it is anymore palatable than that they gave their child autism by

giving them the MMR.

Of course there are always cranks and crackpots, and the anti-vaccine

movement has a long and not so illustrious history preceding the MMR

controversy, but looking at the comments from these parents in many of

the above discussions it struck me that something many of them

mentioned was the gut symptoms that their autistic children showed.

This has been something of a focus of Wakefield, who originally set

out to blame Crohn's disease on measles infection. So how many people

would we expect to show this association?

MMR is given in two injections at ages 1-5yrs, on a back of the

envelope calculation (assuming no connection, which may well not be

valid), if we just look at proper inflammatory bowel disease rather

than just vague gut symptoms we find that taking annual incidence of

6/100k for IBD, and 8/10k for autism spectrum, and estimating around 4

million of the little blighters in the UK, that we'd only expect about

one child to show both over that period.

However, if we broaden our coverage to gut symptoms in general we get

a rather different story, it turns out that GI symptoms are rather

common, with some 16% of 10-11yr olds (you find the data for the under

5s!) fulfilling criteria for recurrent abdominal pain, and 2% showing

lymphonodular hyperplasia on endoscopy, suggesting several hundred

autistic spectrum children with lymphoid changes in the 1-5yr old age

range. Funnily enough it is ileal lymphonodular hyperplasia that

Wakefield reports as being associated with autism (with gut symptoms),

rather than true IBD, and it looks like he will have a steady supply

of patients with the right symptoms and timing to keep supporting him.

An interesting review appeared recently in Histopathology:

Aims: To review the literature on the histopathological diagnosis

of the condition termed `autistic enterocolitis'.

Methods and results: We have reviewed all published works where

mucosal biopsy specimens from autistic children have been examined

histopathologically. Abstracts were excluded. Our review of the

published works, nearly all from a single centre, identifies major

inconsistencies between studies, lack of appropriate controls and

misinterpretation of normal findings as pathology. Ileal lymphoid

hyperplasia may be more prevalent in children with regressive

autism but is also seen in children with food allergies and severe

constipation, the latter being an extremely common finding in

autistic children.

Conclusion: The histopathological diagnosis of autistic

enterocolitis should be treated with caution until a proper study

with appropriate methodology and controls is undertaken.

And concluded:

There is no doubt that autistic children suffer considerable gut

symptoms and these have a significant effect on their quality of

life. But is the claim that these children have an underlying IBD

justified? We can only speculate why severe constipation was not

acknowledged as a significant gut symptom in the original paper1

and was revealed only in correspondence.8 Having accepted, however,

that this was a major problem in these children, subsequent studies

from this group should have explicitly included developmentally

normal children with severe constipation as the appropriate control

group. The conclusions of the 1998 and 2000 papers from the Royal

Free must therefore be regarded as unreliable because of the use of

inappropriate controls. By the time this group did include a

control group with ILNH and constipation and indeed reported the

lack of significant difference in mucosal pathology between

autistic children and controls,3 media and public opinion were

already entrenched.

Significant bias was introduced to the studies from the Royal Free

by the interpretation of histological changes seen in normal

lymphoid follicles as pathology...It is also disturbing that the

investigators have not attempted to re-inforce the

histopathological diagnosis of enterocolitis by having the slides

examined in an open forum by independent pathologists, especially

since another small series has found no abnormalities...

There is no evidence from the papers discussed above that a

significant number of autistic children have `enteritis', i.e.

inflammation of the small intestine. The only consistent

abnormality seen in these children may be ILNH, but we have

explained why this finding is not unexpected in constipated

individuals...

Evidence has been presented to suggest that autistic children have

a `colitis'. In their efforts to present convincing findings,

however, the authors have failed to use appropriate controls and

rigorous methodology, leading to serious flaws and unreliable

conclusions...As to the aetiology of the colitis in autistic

children, there is no convincing evidence that the changes are due

to the autism per se. Indeed, as pointed out in the Royal Free

papers, many autistic children have severe constipation and/or food

allergy, either of which could be responsible for the pathological

abnormalities seen. Other possible causes of inflammation in these

children include parasitic infestation and swallowing foreign

bodies.

...

In conclusion, we are highly sceptical that `autistic

enterocolitis' is a genuine histopathological entity in children

with regressive autism. Further studies with rigorous methodology

and appropriate control groups could be carried out, but if these

are not possible, the histology slides from the autistic children


No comments: